Literature DB >> 24569779

TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.

Z-Z Yang1, D M Grote1, B Xiu2, S C Ziesmer1, T L Price-Troska1, L S Hodge1, D M Yates1, A J Novak1, S M Ansell1.   

Abstract

Transforming growth factor beta (TGF-β) has an important role in mediating T-cell suppression in B-cell non-Hodgkin lymphoma (NHL). However, the underlying mechanism responsible for TGF-β-mediated inhibition of effector memory T (Tm) cells is largely unknown. As reported here, we show that exhaustion is a major mechanism by which TGF-β inhibits Tm cells, and TGF-β mediated exhaustion is associated with upregulation of CD70. We found that TGF-β upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells. CD70 induction by TGF-β is Smad3-dependent and involves IL-2/Stat5 signaling. CD70+ T cells account for TGF-β-induced exhaustion of effector Tm cells. Both TGF-β-induced and preexisting intratumoral CD70+ effector Tm cells from B-cell NHL have an exhausted phenotype and express higher levels of PD-1 and TIM-3 compared with CD70- T cells. Signaling transduction, proliferation and cytokine production are profoundly decreased in these cells, and they are highly susceptible to apoptosis. Clinically, intratumoral CD70-expressing T cells are prevalent in follicular B-cell lymphoma (FL) biopsy specimens, and increased numbers of intratumoral CD70+ T cells correlate with an inferior patient outcome. These findings confirm TGF-β-mediated effector Tm cell exhaustion as an important mechanism of immune suppression in B-cell NHL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569779      PMCID: PMC4145058          DOI: 10.1038/leu.2014.84

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  55 in total

1.  Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor.

Authors:  Julien C Marie; Denny Liggitt; Alexander Y Rudensky
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.

Authors:  Jianping Huang; Keith W Kerstann; Mojgan Ahmadzadeh; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.

Authors:  Won-Woo Lee; Zhi-Zhang Yang; Guangjin Li; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

4.  Nonredundant roles for Stat5a/b in directly regulating Foxp3.

Authors:  Zhengju Yao; Yuka Kanno; Marc Kerenyi; Geoffrey Stephens; Lydia Durant; Wendy T Watford; Arian Laurence; Gertraud W Robinson; Ethan M Shevach; Richard Moriggl; Lothar Hennighausen; Changyou Wu; John J O'Shea
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

5.  Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus.

Authors:  B K Han; A M White; K H Dao; D R Karp; E K Wakeland; L S Davis
Journal:  Lupus       Date:  2005       Impact factor: 2.911

6.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

7.  PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.

Authors:  Simona Urbani; Barbara Amadei; Daniela Tola; Marco Massari; Simona Schivazappa; Gabriele Missale; Carlo Ferrari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

8.  Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation.

Authors:  Ruth R French; Vadim Y Taraban; Graham R Crowther; Tania F Rowley; Juliet C Gray; Peter W Johnson; Alison L Tutt; Aymen Al-Shamkhani; Martin J Glennie
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

9.  Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.

Authors:  Michelle D'Souza; Andrew P Fontenot; Doug G Mack; Catherine Lozupone; Stephanie Dillon; Amie Meditz; Cara C Wilson; Elizabeth Connick; Brent E Palmer
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

Review 10.  TGFbeta signalling in control of T-cell-mediated self-reactivity.

Authors:  Yuri P Rubtsov; Alexander Y Rudensky
Journal:  Nat Rev Immunol       Date:  2007-06       Impact factor: 53.106

View more
  46 in total

Review 1.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

Review 2.  Role of the microenvironment across histological subtypes of NHL.

Authors:  Karin Tarte
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.

Authors:  Klaus Ley; Norbert Gerdes; Holger Winkels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-30       Impact factor: 8.311

4.  Fundamentals of immunology for understanding immunotherapy for lymphoma.

Authors:  Stephen M Ansell
Journal:  Blood Adv       Date:  2020-11-24

5.  T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses.

Authors:  Rachel E O'Neill; Wei Du; Hemn Mohammadpour; Emad Alqassim; Jingxin Qiu; George Chen; Philip L McCarthy; Kelvin P Lee; Xuefang Cao
Journal:  J Immunol       Date:  2017-10-18       Impact factor: 5.422

Review 6.  A new therapeutic target: the CD69-Myl9 system in immune responses.

Authors:  Motoko Y Kimura; Ryo Koyama-Nasu; Ryoji Yagi; Toshinori Nakayama
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

Review 7.  Fundamentals of immunology for understanding immunotherapy for lymphoma.

Authors:  Stephen M Ansell
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

8.  Cytokine signature associated with disease severity in chronic fatigue syndrome patients.

Authors:  Jose G Montoya; Tyson H Holmes; Jill N Anderson; Holden T Maecker; Yael Rosenberg-Hasson; Ian J Valencia; Lily Chu; Jarred W Younger; Cristina M Tato; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

9.  Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.

Authors:  Peter J Siska; Gerritje J W van der Windt; Rigel J Kishton; Sivan Cohen; William Eisner; Nancie J MacIver; Arnon P Kater; J Brice Weinberg; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2016-08-10       Impact factor: 5.422

Review 10.  'Trained immunity': consequences for lymphoid malignancies.

Authors:  Wendy B C Stevens; Mihai G Netea; Arnon P Kater; Walter J F M van der Velden
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.